Article info
Colon
Original article
SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer
- Correspondence to Dr Honghe Zhang and Prof. Maode Lai, Department of Pathology, Key Laboratory of Disease Proteomics of Zhejiang Province, School of Medicine, Zhejiang University, Hangzhou 310058, China; honghezhang{at}zju.edu.cn, lmp{at}zju.edu.cn
Citation
SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer
Publication history
- Received August 2, 2017
- Revised September 25, 2017
- Accepted October 21, 2017
- First published November 7, 2017.
Online issue publication
December 07, 2018
Article Versions
- Previous version (7 November 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.